Amlodipine inhibits proliferation, invasion, and colony formation of breast cancer cells

Alqudah,Mohammad A.Y.; Al‑Samman,Raneem; Azaizeh,Marwah; Alzoubi,Karem H.

doi:10.3892/br.2022.1533

Amlodipine inhibits proliferation, invasion, and colony formation of breast cancer cells

Authors:
- Mohammad A.Y. Alqudah
- Raneem Al‑Samman
- Marwah Azaizeh
- Karem H. Alzoubi
View Affiliations

Affiliations: Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, The University of Sharjah, Sharjah 27272, United Arab Emirates, Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan
Published online on: May 6, 2022 https://doi.org/10.3892/br.2022.1533
Article Number: 50

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Calcium channel upregulation has been implicated in cancer cell proliferation and progression including in breast cancer. Fortunately, the function of calcium channels can be manipulated pharmacologically using calcium channel blockers (CCBs). Amlodipine, a dihydropyridine CCB, has been demonstrated to exert cytotoxic effects in several types of cancers. The present study evaluated the effects of amlodipine on proliferation, caspase activation, colony formation, and invasion of human breast cancer cells. Cell viability was assessed using a colorimetric MTT assay. An Apo‑ONE® caspase‑3/7 assay was used to measure caspase‑3/7 levels. Cell invasion was evaluated using Matrigel invasion chambers. The expression of phospho‑(p‑)ERK1/2, Bcl‑2, and integrin β1 proteins were analyzed using western blotting. A one‑way ANOVA with a post‑hoc Tukey's multiple comparison tests was used for statistical analysis. Amlodipine significantly inhibited the growth of both MDA‑MB‑231 and MCF‑7 human breast cancer cells in a dose‑dependent manner and inhibited colony formation of MCF‑7 cells, and this was accompanied by the downregulation of p‑ERK1/2 in MDA‑MB‑231 cells. In addition, treatment with amlodipine resulted in increased caspase‑3/7 levels in MDA‑MB‑231 cells, which was accompanied by the downregulation of the anti‑apoptotic protein, Bcl‑2. Moreover, amlodipine impaired the invasive abilities of MDA‑MB‑231 cells, and integrin β1 expression was concurrently downregulated. The present study illustrates the anticancer effects of amlodipine on breast cancer proliferation, colony formation, and invasion in vitro and highlights the potential value of amlodipine as an anticancer agent.

View Figures

View References

1	Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.PubMed/NCBI View Article : Google Scholar
2	Siegel RL, Miller KD, Fuchs HE and Jemal A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.PubMed/NCBI View Article : Google Scholar
3	World Health Organization. Jordan-Global Cancer Observatory [Fact sheet] 2020, December. Available from: https://gco.iarc.fr/today/data/factsheets/populations/400-jordan-fact-sheets.pdf.
4	Seyfried TN and Huysentruyt LC: On the origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013.PubMed/NCBI View Article : Google Scholar
5	van Zijl F, Krupitza G and Mikulits W: Initial steps of metastasis: Cell invasion and endothelial transmigration. Mutat Res. 728:23–34. 2011.PubMed/NCBI View Article : Google Scholar
6	Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR (eds), et al: SEER cancer statistics review, 1975-2017, National Cancer Institute. Bethesda, MD, 2020. Available from: https://seer.cancer.gov/csr/1975_2017/.
7	American Cancer Society. Breast cancer facts and figures 2019-2020: American Cancer Society, 2020. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2019-2020.pdf.
8	Carrick S, Parker S, Thornton CE, Ghersi D, Simes J and Wilcken N: Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database Syst Rev: Apr 15, 2009 (Epub ahead of print). doi: 10.1002/14651858.CD003372.pub3.
9	Boster BL, Patel NK and Michaud LB: Breast cancer. In: Pharmacotherapy: A Pathophysiologic Approach, 11e. DiPiro JT, Yee GC, Posey LM, Haines ST, Nolin TD and Ellingrod V (eds). McGraw-Hill Education, New York, NY, 2020.
10	Velaei K, Samadi N, Barazvan B and Soleimani Rad J: Tumor microenvironment-mediated chemoresistance in breast cancer. Breast. 30:92–100. 2016.PubMed/NCBI View Article : Google Scholar
11	Wilson LE, D'Aloisio AA, Sandler DP and Taylor JA: Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women. Breast Cancer Res. 18(61)2016.PubMed/NCBI View Article : Google Scholar
12	Lee AR, Seo MJ, Kim J, Lee DM, Kim IY, Yoon MJ, Hoon H and Choi KS: Lercanidipine synergistically enhances bortezomib cytotoxicity in cancer cells via enhanced endoplasmic reticulum stress and mitochondrial Ca²⁺ overload. Int J Mol Sci. 20(6112)2019.PubMed/NCBI View Article : Google Scholar
13	Alqudah MAY, Alrababah BA and Mhaidat NM: Amlodipine inhibits cell proliferation and induces cell cycle arrest in colorectal cancer cells. Jordan J Pharm Sci. 10:189–197. 2017.
14	Ji BS, He L and Liu GQ: Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Life Sci. 77:2221–2232. 2005.PubMed/NCBI View Article : Google Scholar
15	Yoshida J, Ishibashi T and Nishio M: Antitumor effects of amlodipine, a Ca²⁺ channel blocker, on human epidermoid carcinoma A431 cells in vitro and in vivo. Eur J Pharmacol. 492:103–112. 2004.PubMed/NCBI View Article : Google Scholar
16	Alqudah MA, Agarwal S, Al-Keilani MS, Sibenaller ZA, Ryken TC and Assem M: NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR. PLoS One. 8(e77299)2013.PubMed/NCBI View Article : Google Scholar
17	Al-Oudat BA, Alqudah MA, Audat SA, Al-Balas QA, El-Elimat T, Hassan MA, Frhat IN and Azaizeh MM: Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators. Drug Des Devel Ther. 13:423–433. 2019.PubMed/NCBI View Article : Google Scholar
18	Siragusa M, Dall'Olio S, Fredericia PM, Jensen M and Groesser T: Cell colony counter called CoCoNut. PLoS One. 13(e0205823)2018.PubMed/NCBI View Article : Google Scholar
19	Ayoub NM, Alkhalifa AE, Ibrahim DR and Alhusban A: Combined crizotinib and endocrine drugs inhibit proliferation, migration, and colony formation of breast cancer cells via downregulation of MET and estrogen receptor. Med Oncol. 38(8)2021.PubMed/NCBI View Article : Google Scholar
20	Ayoub NM, Al-Shami KM, Alqudah MA and Mhaidat NM: Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents. Onco Targets. 10:4869–4883. 2017.PubMed/NCBI View Article : Google Scholar
21	Alqudah MAY, Azaizeh M, Zayed A and Asaad L: Calcium-sensing receptor antagonist NPS-2143 inhibits breast cancer cell proliferation, migration and invasion via downregulation of p-ERK1/2, Bcl-2 and integrin β1 and induces caspase 3/7 activation. Adv Pharm Bull. 12:383–388. 2022.
22	Brentnall M, Rodriguez-Menocal L, De Guevara RL, Cepero E and Boise LH: Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 14(32)2013.PubMed/NCBI View Article : Google Scholar
23	Jänicke RU: MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Treat. 117:219–221. 2009.PubMed/NCBI View Article : Google Scholar
24	Kottke TJ, Blajeski AL, Meng XW, Svingen PA, Ruchaud S, Mesner PW Jr, Boerner SA, Samejima K, Henriquez NV, Chilcote TJ, et al: Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells. J Biol Chem. 277:804–815. 2002.PubMed/NCBI View Article : Google Scholar
25	Comşa Ş, Cîmpean AM and Raica M: The story of MCF-7 breast cancer cell line: 40 Years of experience in research. Anticancer Res. 35:3147–3154. 2015.PubMed/NCBI
26	Yamakage M and Namiki A: Calcium channels-basic aspects of their structure, function and gene encoding; anesthetic action on the channels-a review. Can J Anaesth. 49:151–164. 2002.PubMed/NCBI View Article : Google Scholar
27	Phan NN, Wang CY, Chen CF, Sun Z, Lai MD and Lin YC: Voltage-gated calcium channels: Novel targets for cancer therapy. Oncol Lett. 14:2059–2074. 2017.PubMed/NCBI View Article : Google Scholar
28	Prevarskaya N, Skryma R and Shuba Y: Ion channels and the hallmarks of cancer. Trends Mol Med. 16:107–121. 2010.PubMed/NCBI View Article : Google Scholar
29	Varghese E, Samuel SM, Sadiq Z, Kubatka P, Liskova A, Benacka J, Pazinka P, Kruzliak P and Büsselberg D: Anti-cancer agents in proliferation and cell death: The calcium connection. Int J Mol Sci. 20(3017)2019.PubMed/NCBI View Article : Google Scholar
30	Jacquemet G, Baghirov H, Georgiadou M, Sihto H, Peuhu E, Cettour-Janet P, He T, Perälä M, Kronqvist P, Joensuu H and Ivaska J: L-type calcium channels regulate filopodia stability and cancer cell invasion downstream of integrin signalling. Nat Commun. 7(13297)2016.PubMed/NCBI View Article : Google Scholar
31	Kanwar N, Carmine-Simmen K, Nair R, Wang C, Moghadas-Jafari S, Blaser H, Tran-Thanh D, Wang D, Wang P, Wang J, et al: Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasis. EBioMedicine. 52(102646)2020.PubMed/NCBI View Article : Google Scholar
32	Ji Y, Han Z, Shao L and Zhao Y: Ultrasound-targeted microbubble destruction of calcium channel subunit α 1D siRNA inhibits breast cancer via G protein-coupled receptor 30. Oncol Rep. 36:1886–1892. 2016.PubMed/NCBI View Article : Google Scholar
33	Zhang GJ, Kimijima I, Tsuchiya A and Abe R: The role of bcl-2 expression in breast carcinomas (Review). Oncol Rep. 5:1211–1216. 1998.PubMed/NCBI View Article : Google Scholar
34	Pratt MA, Niu M and White D: Differential regulation of protein expression, growth and apoptosis by natural and synthetic retinoids. J Cell Biochem. 90:692–708. 2003.PubMed/NCBI View Article : Google Scholar
35	Lan L, Xinghua X, Wenjuan S and Liying D: Effect of amlodipine on apoptosis of human breast carcinoma MDA-MB-231 cells. J Med Coll PLA. 23:358–363. 2008.PubMed/NCBI View Article : Google Scholar
36	Wong BS, Chiu LY, Tu DG, Sheu GT and Chan TT: Anticancer effects of antihypertensive L-type calcium channel blockers on chemoresistant lung cancer cells via autophagy and apoptosis. Cancer Manag Res. 12:1913–1927. 2020.PubMed/NCBI View Article : Google Scholar
37	Shiozaki A, Katsurahara K, Kudou M, Shimizu H, Kosuga T, Ito H, Arita T, Konishi H, Komatsu S, Kubota T, et al: Amlodipine and verapamil, voltage-gated Ca²⁺ channel inhibitors, suppressed the growth of gastric cancer stem cells. Ann Surg Oncol. 28:5400–5411. 2021.PubMed/NCBI View Article : Google Scholar
38	Panneerpandian P, Rao DB and Ganesan K: Calcium channel blockers lercanidipine and amlodipine inhibit YY1/ERK/TGF-β mediated transcription and sensitize the gastric cancer cells to doxorubicin. Toxicol In Vitro. 74(105152)2021.PubMed/NCBI View Article : Google Scholar
39	Li Y, Liu S, Lu F, Zhang T, Chen H, Wu S and Zhuang H: A role of functional T-type Ca²⁺ channel in hepatocellular carcinoma cell proliferation. Oncol Rep. 22:1229–1235. 2009.PubMed/NCBI View Article : Google Scholar
40	Lee H, Kim JW, Kim DK, Choi DK, Lee S, Yu JH, Kwon OB, Lee J, Lee DS, Kim JH and Min SH: Calcium channels as novel therapeutic targets for ovarian cancer stem cells. Int J Mol Sci. 21(2327)2020.PubMed/NCBI View Article : Google Scholar
41	Granados K, Hüser L, Federico A, Sachindra S, Wolff G, Hielscher T, Novak D, Madrigal-Gamboa V, Sun Q, Vierthaler M, et al: T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cells. Br J Cancer. 122:1023–1036. 2020.PubMed/NCBI View Article : Google Scholar
42	Jacquemet G, Hamidi H and Ivaska J: Filopodia in cell adhesion, 3D migration and cancer cell invasion. Curr Opin Cell Biol. 36:23–31. 2015.PubMed/NCBI View Article : Google Scholar
43	Jacquemet G, Green DM, Bridgewater RE, von Kriegsheim A, Humphries MJ, Norman JC and Caswell PT: RCP-driven α5β1 recycling suppresses Rac and promotes RhoA activity via the RacGAP1-IQGAP1 complex. J Cell Biol. 202:917–935. 2013.PubMed/NCBI View Article : Google Scholar
44	Hou S, Isaji T, Hang Q, Im S, Fukuda T and Gu J: Distinct effects of β1 integrin on cell proliferation and cellular signaling in MDA-MB-231 breast cancer cells. Sci Rep. 6(18430)2016.PubMed/NCBI View Article : Google Scholar
45	Yin HL, Wu CC, Lin CH, Chai CY, Hou MF, Chang SJ, Tsai HP, Hung WC, Pan MR and Luo CW: β1 integrin as a prognostic and predictive marker in triple-negative breast cancer. Int J Mol Sci. 17(1432)2016.PubMed/NCBI View Article : Google Scholar
46	Thibaudeau L, Taubenberger AV, Theodoropoulos C, Holzapfel BM, Ramuz O, Straub M and Hutmacher DW: New mechanistic insights of integrin β1 in breast cancer bone colonization. Oncotarget. 6:332–344. 2015.PubMed/NCBI View Article : Google Scholar